Biotech IPOs are heating up.
Biotech companies are moving
toward an IPO company model
with six of them (Audentes
Therapeutics, Bavarian Nordic, Corvus
Pharmaceuticals, Editas Medicine, Reata
Pharmaceuticals, Syndax Pharmaceuticals)
announcing public offerings on January 4, 2016.
71% of biotech firms have funded themselves
through the equity markets, while 34% have
received funding from credit markets.
Source: Health Tech Zone, “Why are so many biotech
startups filing IPOs in 2016?” 01/07/2016
A sales or marketing mis-hire costs
There is a high cost to both poor hiring and
leaving positions open. The cost of a marketing
or sales mis-hire is approximately $82K. The
monthly cost for each open sales position is
on average $45K, while the cost of an open
marketing position is $39K.
Source: Jacobs Management Group, “Annual
Compensation and Hiring Survey”
The top four vaccine companies are expected to hold over 80% of the
vaccine sales market worldwide.
FDA approved 30 new PMAs in 2015, a 50% increase By 2020, Merck & Co,
GlaxoSmithKline, Sanofi and Pfizer are each predicted to capture 21% of the
worldwide vaccine market. The top 10 companies will hold over 93% of the
$34B worldwide market.
Source:EvaluatePharma, 2015 Worldwide Preview “Outlook to 2020,” June, 2015
Telehealth has arrived.
Telehealth has become a reality. Telehealth services have been
estimated at $14.4B in 2015 with an expected growth to $34.4B
in 2020. The US market leads the way with a 40% market share.
Source: Mordor Intelligence “Global Telemedicine Marketing –
Growth, Trend and Forecasts (2105-2020),” December 2015